Indole and benzothiophene compounds as modulators of the histamine H3 receptor

Details for Australian Patent Application No. 2008223142 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Santillan Jr., Alejandro; McClure, Kelly J.; Grice, Cheryl A.; Allison, Brett D.

Agent Shelston IP

Pub. Number AU-A-2008223142

PCT Pub. Number WO2008/109333

Priority 60/892,330 01.03.07 US

Filing date 28 February 2008

Wipo publication date 12 September 2008

International Classifications

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 September 2009 PCT application entered the National Phase

  PCT publication WO2008/109333 Priority application(s): WO2008/109333

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223144-Game with chance element or event simulation

2008223133-Use of copper and glutamate in cell culture for production of polypeptides